Aim: To evaluate the stigma and its correlates among patients with severe mental disorders. Methodology: Patients with diagnosis of schizophrenia (N=707), bipolar disorder (N=344) and recurrent depressive disorder (N=352) currently in clinical remission from 14 participating centres were assessed on Internalised Stigma of Mental Illness Scale (ISMIS) and Participation Scale (P-Scale).
Neuroinflammation in depression -serum cytokines as an indicator
Surg Cdr (Retd) KSHIROD K MISHRA Prof & Head, Psychiatry, JNMC, Wardha drkkmishra2003@yahoo.co.uk Background: Dysfunction of the innate immune system leading to neuroinflammation has been increasingly implicated in patho physiology of numerous psychiatric disorders including major depressive disorder.
Aims & Objectives: The study was aimed at finding-I) The levels of proinflammatory cytokines in the serum of first episode depressive patients in comparison to healthy individuals. II) To compare the level of serum cytokines after the treatment with conventional antidepressants. Materials & Methods: 50 consecutive cases of first episode depressive patients diagnosed by ICD-10 diagnostic criteria were included in the study sample by purposive sampling technique. Subjects were evaluated clinically using a semi-structured proforma. The severity of depression was measured by HAM-D. Beck's Scale for Suicide Inventory was used to exclude any case with suicide ideation .Blood samples were collected from the cases prior to starting the antidepressant medication and from the control at the time of the entry for the study. Serum cytokines (IL-1B, IL-6, and TNF-Alpha) estimation was done by ELISA technique using human cytokine kits. The psychometric tests and serum cytokines levels were repeated after 6 weeks and 6 months of treatment with conventional antidepressants. The values obtained were statistically analyzed using SPSS version 10 Results: Analysis of data showed significant higher values of IL-6 and TNF α in depressive patients in comparison to healthy controls. The levels of cytokines reduced significantly following the treatment. Conclusion: There was a definite rise in the levels of pro inflammatory cytokines in depressed patients which reduce substantially following the treatment with antidepressants. Further studies in this line can be helpful for development of cytokine based therapy in depression. The most commonly studied & discussed psychiatric disorder, the Post Traumatic Stress Disorder (PTSD), is so excessively emphasized that it has become "Sine Quo Non" with disaster mental health. Literature has reported generally high, and sometimes variable, rates of PTSD in the short term & long term consequences of disasters. Many studies have reported high rates of PTSD in non-systematic hospital or field sample, in the absence of standardized methods. This paper reports on the prevalence of psychiatric disorders, with specific reference to PTSD in a large epidemiological sample, across three research sites, with modified cohort design, and two stage method using GHQ and MARFATIA AWARD AWARDS Abstracts Indian J Psychiatry 59 (Supplement 2), January 2017 S147 Background: Use of natural opioids is socio-culturally accepted and has been reported across various parts of India. Systematic studies assessing the clinical profile, quality of life and severity of dependence of natural opiates users among the treatment seeking individuals are unavailable.
Aims and Objectives:
The study aimed to assess the socio-demographic profile, clinical profile, addiction severity and quality of life in treatmentseeking users of natural opiates (poppy husk and opium).
Settings and design:
This cross-sectional exploratory study was conducted at the National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, a tertiary care hospital located in North India. Materials and methods: This is an observational study of 100 male subjects (aged 18 to 65), users of natural opiates (opium and poppy husk) seeking outpatient treatment at NDDTC, AIIMS. Information pertaining to socio-demographic data, and substance use and clinical profile was obtained. In addition, quality of life (using WHO Quality of Life-BREF version) and addiction severity (using Addiction Severity Index-Lite version) were also assessed. Results: All the subjects were male with a mean age of 44.6 (±11.0) years. 97/100 reported using poppy husk ("doda" or "bhukki") daily in a dependent pattern with age of onset of 28.1±8.3 years. The most common reasons for initiation of opiate use were out of curiosity/experimentation (n=63) followed by peer pressure (n=59). Prior abstinence attempts rate was low (n=21) while only 6/100 participants sought treatment before coming to our centre. The most common reason for seeking treatment was an inability to afford opiates (n=72). Rates of medical, familial, social, psychological and legal complications were low. Conclusion: Natural opiate users seem to be a unique subpopulation of treatment seeking substance users with fewer/no complications despite the long duration of uninterrupted opiate use. There is a need to study their clinical needs in more depth for adequate management of these patients.
Key words: Afim, Doda, Bhukki, Natural opiates, Opium. Results: About one third (37%) of patients experienced internalized stigma. On the basis of mean scores of various domains of ISMIS, two-fifth (40%) of participants reported discrimination experience and stereotype endorsement and this was followed by stigma resistance (37.3%) and social withdrawal (30.7%). About one-fourth (25.3%) of the sample was found to have depression. Comorbid depression was associated with significantly higher stigma in the domain of stereotype endorsement (p=0.006). Insight as assessed by PANSS-G12 item did not correlate significantly with stigma. Higher cognitive insight in the form of composite score (R-C index) and higher cognitive self-reflectiveness was associated with higher level of stigma in all the domains except for stigma resistance. Higher stigma was associated with negative symptoms, higher disability and lower socio-occupational functioning.
Is there a relationship between internalized stigma, depression and cognitive insight in patients with schizophrenia? : An exploratory study
Conclusion: Present study suggests that internalised stigma is highly prevalent among patients with schizophrenia. In terms of correlates, internalized stigma is not associated with depression. Clinical insight doesn't have any association with stigma, but cognitive insight in the form of self-reflectiveness is associated with higher stigma. Higher level of stigma is associated with more disability and poor functioning. 
